We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement
Metabolon Enters into Collaboration with GSK
News

Metabolon Enters into Collaboration with GSK

Metabolon Enters into Collaboration with GSK
News

Metabolon Enters into Collaboration with GSK

Read time:
 

Want a FREE PDF version of This News Story?

Complete the form below and we will email you a PDF version of "Metabolon Enters into Collaboration with GSK"

First Name*
Last Name*
Email Address*
Country*
Company Type*
Job Function*
Would you like to receive further email communication from Technology Networks?

Technology Networks Ltd. needs the contact information you provide to us to contact you about our products and services. You may unsubscribe from these communications at any time. For information on how to unsubscribe, as well as our privacy practices and commitment to protecting your privacy, check out our Privacy Policy

The collaboration will give GSK access to Metabolon’s bioinformatics tools along with the company’s proprietary disease ontologies, as well as visualization tools that will integrate metabolomics data with existing genomics and proteomics data.  John Ryals, Metabolon President and CEO commented, “We are pleased to announce a collaboration with GSK.  We believe that embedding metabolomic profiling capabilities at the various stages of R&D is important to enhance the phenotypic ‘picture’ with the aim of yielding translatable, meaningful results. Gaps of knowledge can be bridged through the understanding metabolomics provides, which could lead to better targets, higher quality molecules, faster time to the clinic and reduced risk and cost.”

Metabolon, Inc. has completed thousands of metabolomics studies across numerous therapeutic areas and has developed expertise in metabolic pathways and targets that are involved in the onset of disease and its progression.  Metabolon’s technology platforms are robust and known for their rapid, repeatable results.  Expert, credentialed biochemists interpret biological data to yield actionable insight into key disease metabolic processes, drug action, and patient response.

Advertisement